205 related articles for article (PubMed ID: 12717100)
41. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat.
D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ
Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727
[TBL] [Abstract][Full Text] [Related]
42. Comparison of effects of formoterol and BRL 37344 on isolated term-pregnant rat myometrial strips in vitro.
Yurtcu N; Cetin A; Karadas B; Gonca Imir A; Kaya T; Erselcan T; Bagcivan I; Cetin M
Eur J Pharmacol; 2006 Jan; 530(3):263-9. PubMed ID: 16388799
[TBL] [Abstract][Full Text] [Related]
43. Roles of PKA, PI3K, and cPLA2 in the NO-mediated negative inotropic effect of beta2-adrenoceptor agonists in guinea pig right papillary muscles.
Faucher FA; Gannier FE; Lignon JM; Cosnay P; Malécot CO
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C106-17. PubMed ID: 17942637
[TBL] [Abstract][Full Text] [Related]
44. Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists.
Gauthier C; Tavernier G; Trochu JN; Leblais V; Laurent K; Langin D; Escande D; Le Marec H
J Pharmacol Exp Ther; 1999 Aug; 290(2):687-93. PubMed ID: 10411579
[TBL] [Abstract][Full Text] [Related]
45. Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.
Liu YL; Cawthorne MA; Stock MJ
Br J Pharmacol; 1996 Mar; 117(6):1355-61. PubMed ID: 8882636
[TBL] [Abstract][Full Text] [Related]
46. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes.
Xiao RP; Avdonin P; Zhou YY; Cheng H; Akhter SA; Eschenhagen T; Lefkowitz RJ; Koch WJ; Lakatta EG
Circ Res; 1999 Jan 8-22; 84(1):43-52. PubMed ID: 9915773
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery.
Leblais V; Pourageaud F; Ivorra MD; Marthan R; Muller B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):535-9. PubMed ID: 16012871
[TBL] [Abstract][Full Text] [Related]
48. Gastroprotective effect of beta3 adrenoreceptor agonists ZD 7114 and CGP 12177A in rats.
Sevak R; Paul A; Goswami S; Santani D
Pharmacol Res; 2002 Oct; 46(4):351-6. PubMed ID: 12361698
[TBL] [Abstract][Full Text] [Related]
49. Effects of the beta 3-adrenoceptor agonist BRL 37344 on lipomobilization and plasma glucose levels in conscious fasted rabbits.
Reverte M; Rivas-Cabañero L
Can J Physiol Pharmacol; 1996 Mar; 74(3):251-6. PubMed ID: 8773403
[TBL] [Abstract][Full Text] [Related]
50. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
51. Functional evidence of atypical beta 3-adrenoceptors in the human colon using the beta 3-selective adrenoceptor antagonist, SR 59230A.
De Ponti F; Gibelli G; Croci T; Arcidiaco M; Crema F; Manara L
Br J Pharmacol; 1996 Apr; 117(7):1374-6. PubMed ID: 8730727
[TBL] [Abstract][Full Text] [Related]
52. Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.
Briones AM; Daly CJ; Jimenez-Altayo F; Martinez-Revelles S; Gonzalez JM; McGrath JC; Vila E
Br J Pharmacol; 2005 Nov; 146(5):679-91. PubMed ID: 16113691
[TBL] [Abstract][Full Text] [Related]
53. The beta-adrenoceptors mediating relaxation of rat oesophageal muscularis mucosae are predominantly of the beta 3-, but also of the beta 2-subtype.
de Boer RE; Brouwer F; Zaagsma J
Br J Pharmacol; 1993 Sep; 110(1):442-6. PubMed ID: 8106109
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological properties of β-adrenoceptors mediating rat superior mesenteric artery relaxation and the effects of chemical sympathetic denervation.
Obara K; Shigematsu M; Takahasi H; Iiboshi Y; Yoshioka K; Kasuya Y; Tanaka Y
Life Sci; 2020 Jan; 241():117155. PubMed ID: 31837330
[TBL] [Abstract][Full Text] [Related]
55. Functional beta3-adrenoceptor in the human heart.
Gauthier C; Tavernier G; Charpentier F; Langin D; Le Marec H
J Clin Invest; 1996 Jul; 98(2):556-62. PubMed ID: 8755668
[TBL] [Abstract][Full Text] [Related]
56. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
Kaumann AJ; Molenaar P
Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
[TBL] [Abstract][Full Text] [Related]
57. No-dependent vasodilation induced by nebivolol in coronary circulation is not mediated by beta-adrenoceptors or by 5 HT1A-receptors.
Chlopicki S; Kozlovski VI; Gryglewski RJ
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):615-24. PubMed ID: 12512696
[TBL] [Abstract][Full Text] [Related]
58. Influence of adrenodemedullation on beta 2- and beta 3-adrenoceptors mediating relaxation of oesophageal smooth muscle of spontaneously hypertensive rats.
de Boer RE; Steegstra MR; Kroezen PA; Smit J; Zaagsma J
Br J Pharmacol; 1996 Dec; 119(7):1355-60. PubMed ID: 8968543
[TBL] [Abstract][Full Text] [Related]
59. Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.
Shen YT; Cervoni P; Claus T; Vatner SF
J Pharmacol Exp Ther; 1996 Sep; 278(3):1435-43. PubMed ID: 8819531
[TBL] [Abstract][Full Text] [Related]
60. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
Germack R; Starzec AB; Vassy R; Perret GY
Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
